Storia in 2 fonti

ARPA-H selects companies to build AI tools for heart disease

ARPA-H invests $62.7M in ADVOCATE program; UpDoc, Tempus AI & Atman Health to build FDA-authorized AI tools for heart disease care over 4 years.

Raccontata da

endpoints.news

fiercehealthcare.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.news2 g fa

The blueprint for clinical AI

L'articolo non è stato fornito completamente. Vedo solo l'inizio: > "ARPA-H, a federal agency that funds breakthrough health technologies, just kicked off a new program called ADVOCATE that provides millions …" Mi serve il **testo completo dell'articolo** per fare un riassunto preciso secondo le tue regole (2 frasi, max 260 caratteri, focalizzato su fatto centrale + implicazione tech). Puoi fornire il corpo intero dell'articolo?

Leggi questa versione → originale

fiercehealthcare.com20 h fa

ARPA-H launches $63M effort to build FDA-authorized AI agents for heart failure care

ARPA-H launches ADVOCATE ($62.7M) for AI agents monitoring heart failure and escalating to clinicians. First FDA regulatory precedent for generative AI in clinical settings, unlocking reimbursement pathways and deployment; $28 billion annual savings potential.

Timeline cronologica

mercoledì 9 settembre 2026·endpoints.news
ARPA-H selects companies to build AI tools for heart disease
ARPA-H invests $62.7M in ADVOCATE program; UpDoc, Tempus AI & Atman Health to build FDA-authorized AI tools for heart disease care over 4 years.
giovedì 10 settembre 2026·endpoints.news
The blueprint for clinical AI
ARPA-H launched ADVOCATE, funding UpDoc, Tempus AI & Atman Health to build FDA-authorized AI agents for heart failure treatment within 24 months.